Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Anti-Dilution Provisions off Equity Compensation Plans May Need to Be Amended to Avoid Comp

Related Content

How to Write an Effective Public Benefit Report

Federal Reserve Removes References to Reputation and Reputational Risk in Its Supervisory Materials

OCC Reaffirms Federal Preemption Regulations

CFPB Issues Final Rule Removing Requirement for State Officials to Notify CFPB of State Actions Enforcing the CFPA

Healthcare M&A Poised for a Rebound in 2025

Crafting a Competitive LOI in Lower Middle Market M&A

CFPB Withdraws Proposed Rule on Data Broker Practices

Federal Reserve Rescinds Bank Guidance, and the Federal Reserve, FDIC and OCC Withdraw 2023 Joint Statements, Regarding Crypto-Asset and Dollar Token Activities

Goodwin Is Number One Law Firm for Global M&A for H1 2025

Olo to be Taken Private by Thoma Bravo for Approximately $2.0 Billion

Goodwin Represents Superhuman in Agreement to Be Acquired by Grammarly

Goodwin Advised Landmark Bio in Acquisition by Artis BioSolutions to Expand Manufacturing and Commercialization of Advanced Therapies

SpringWorks Therapeutics Completes Acquisition by Merck KGaA, Darmstadt, Germany to Accelerate Sustainable Growth for $3.9 Billion

Fixing a Broken Record (PitchBook)

Stuck Private-Equity Deals Saddle Investors With Endless Fees (The Wall Street Journal)

Goodwin Advises Predibase on Acquisition by Rubrik to Accelerate Agentic AI Adoption

Technology

Mergers & Acquisitions

Capital Markets

ERISA & Executive Compensation